about
Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles.Risk of miscarriage in women with endometriosis: insights from in vitro fertilization cycles.Pregnancy outcome in women with endometriosis achieving pregnancy with IVF.Predicting the success of IVF: external validation of the van Loendersloot's model.Clinical Value of Basal Serum Progesterone Prior to Initiate Ovarian Hyper-Stimulation with GnRH Antagonists: A Retrospective Cohort Study.Frozen-thawed blastocyst transfer in natural cycle: feasibility in everyday clinical practice.Mitochondrial DNA Copy Number in Peripheral Blood in the First Trimester of Pregnancy and Different Preeclampsia Clinical Phenotypes Development: A Pilot StudyReply: On the Reporting of Odds Ratios and Risk Ratios, Nutrients 2018, 10, 10Maternal and Paternal Caffeine Intake and ART Outcomes in Couples Referring to an Italian Fertility Clinic: A Prospective CohortRisk factors for monozygotic twinning after in vitro fertilization: a systematic review and meta-analysisFertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrievedOocyte retrieval difficulties in women with ovarian endometriomasExcessive fetal growth in frozen embryo transfer: false alarm or clinical concern?Peripheral Estrogens in Women with Endometriosis Undergoing IVFEffect of vitamin D supplementation on assisted reproduction technology (ART) outcomes and underlying biological mechanisms: protocol of a randomized clinical controlled trial. The "supplementation of vitamin D and reproductive outcome" (SUNDRO) stuHow common is real repeated implantation failure? An indirect estimate of the prevalenceOocyte quality in women with thalassaemia major: insights from IVF cycles
P50
Q33698899-D101C523-80BD-4E76-9682-6C8FA9AF0E28Q38811260-C06D94B5-80DD-441A-AAC9-1B93DEF4AE58Q39354593-93B4444D-64CD-4541-A762-1894D2A4EFFCQ39852398-F019D7F1-ADCE-4F9A-933E-3CF643B64F97Q51572913-C40D0BE4-A077-4678-948C-BA22787DCA62Q53324156-5E69611C-25A5-49E3-8EB6-0DAF190D4047Q57296049-84669774-DAF8-4CA4-A429-8F62ACE52713Q58115782-C6540F4D-2B04-432E-B1C5-74E47F6DAA00Q58768323-29695E90-546E-4D2F-BC19-E954110EE289Q61855472-68570D68-4D1B-4BFF-BEFB-1E22DDC6C755Q61855476-1A5A28CB-A8E1-4685-9C35-819A7FE9520EQ61855483-F802F958-A16F-4228-AC3B-F2CFAF842EFAQ61855486-2748CC57-536C-41B1-B954-BCF2C3F19C7DQ89660299-58153404-310D-42C3-9755-693E09F6BB35Q91058681-8DBD804A-48C3-4CD6-9910-E1DC59B9CD45Q92561398-A568474D-CDEB-44B0-9411-441E131F7A64Q92566075-68626848-F430-4191-B706-B5B11B1DEB98
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marco Reschini
@ast
Marco Reschini
@en
Marco Reschini
@es
Marco Reschini
@nl
Marco Reschini
@sl
type
label
Marco Reschini
@ast
Marco Reschini
@en
Marco Reschini
@es
Marco Reschini
@nl
Marco Reschini
@sl
prefLabel
Marco Reschini
@ast
Marco Reschini
@en
Marco Reschini
@es
Marco Reschini
@nl
Marco Reschini
@sl
P106
P21
P31
P496
0000-0002-9868-3043